Analyze Diet

Retrospective evaluation of 155 adult equids and 21 foals with tetanus from Western, Northern, and Central Europe (2000-2014). Part 2: Prognostic assessment.

Abstract: To identify prognostic variables for adult equids and foals with tetanus. Methods: Multicenter retrospective study (2000-2014). Methods: Twenty Western, Northern, and Central European university teaching hospitals and private referral centers. Methods: One hundred fifty-five adult equids and 21 foals with tetanus. Methods: None. Results: Variables from history and clinical examination were statistically compared between survivors and nonsurvivors (adults: 49 survivors, 85 nonsurvivors; foals: 7 survivors, 10 nonsurvivors). Cases euthanized for financial reasons were excluded. Mortality rates in adults and foals were 68.4% and 66.7%, respectively. Variables associated with survival in adults included: standing, normal intestinal sounds and defecation, voluntarily drinking, eating soft or normal food, lower heart and respiratory rates, high base excess on admission, longer diagnosis time, treatment and hospitalization delay, and mild severity grade. Variables associated with death included: anorexia, dysphagia, dyspnea, low blood potassium concentration on admission, moderate and severe disease grading, development of dysphagia, dyspnea, recumbency and seizures during hospitalization, treatment with glycerol guaiacolate, intravenous fluids, and intravenous glucose solutions. Variables associated with survival in foals included standing on admission, voluntarily eating soft food and drinking, older age, and longer hospitalization delay. Outcome was not different between different tetanus antitoxin (TAT) dosages, although there was a trend of increasing survival rate with increasing TAT dosages. Cases with appropriate vaccination prior to development of tetanus were rare, but had improved outcome and shorter hospitalization. Conclusions: Prognosis for equine tetanus is poor with similar outcome and prognostic factors in foals and adults. The prognostic assessment of cases with tetanus provides clinicians with new evidence-based information related to patient management. Several prognostic indicators relate to the ability to eat or drink, and more severe clinical signs relate to poor outcome. Increasing intravenous dosages of TAT has no significant effect on outcome, but the positive trend identified may support a recommendation for high intravenous TAT dosages. Further evaluation is warranted.
Publication Date: 2017-09-28 PubMed ID: 28960891DOI: 10.1111/vec.12669Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Multicenter Study

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper investigates the factors that determine the prognosis of adult horses and foals suffering from tetanus. The authors carried out a multicenter retrospective study on 176 cases in Western, Northern, and Central Europe. The goal was to understand what variables might predict survival rates. Overall, the prognosis for equine tetanus was found to be poor.

Methodology

The study was done retrospectively, looking at 155 adult equine and 21 foal tetanus cases from 20 different teaching hospitals and private referral centers across Central, Northern, and Western Europe. Variables from patient histories and clinical examinations were collected and statistically compared between cases that survived and those that did not.

  • Nonsurvivors: 85 adults and 10 foals.
  • Survivors: 49 adults and 7 foals.

Cases that were euthanized for financial reasons were excluded from the study.

Results

The mortality rates for adult equines and foals were 68.4% and 66.7% respectively.

  • The survival variables for adults were: standing, normal intestinal sounds and defecation, voluntarily drinking, eating soft or normal food, lower heart and respiratory rates, high base excess on admission, longer diagnosis time, treatment and hospitalization delay, and mild severity grade.
  • The prognostic variables of death in adults were: anorexia, dysphagia, dyspnea, low blood potassium concentration on admission, moderate and severe disease grading, development of dysphagia, dyspnea, recumbency and seizures during hospitalization, treatment with glycerol guaiacolate, intravenous fluids, and intravenous glucose solutions.
  • The survival variables for foals were: standing on admission, voluntarily eating soft food and drinking, older age, and longer hospitalization delay.

The outcome between different dosages of the tetanus antitoxin(TAT) was not significantly different. However, there was a trend noted that the survival rate increased with higher TAT dosages. Cases with appropriate vaccinations prior to the development of tetanus were rare, but had better outcomes and shorter hospital stays.

Conclusions

Based on the study’s findings, the prognosis for equine tetanus is generally poor for both adults and foals. Several prognostic indicators were related to the ability to eat or drink and more severe clinical signs correlated to poor outcomes. Overall, the study provides valuable data that can guide future patient management and offers a foundation for further studies on high dosages of TAT and the positive trend identified associated with its use.

Cite This Article

APA
van Galen G, Rijckaert J, Mair T, Amory H, Armengou L, Bezdekova B, Durie I, Findshøj Delany R, Fouché N, Haley L, Hewetson M, van den Hoven R, Kendall A, Malalana F, Muller Cavalleri J, Picavet T, Roscher K, Verwilghen D, Westermann C, Saegerman C. (2017). Retrospective evaluation of 155 adult equids and 21 foals with tetanus from Western, Northern, and Central Europe (2000-2014). Part 2: Prognostic assessment. J Vet Emerg Crit Care (San Antonio), 27(6), 697-706. https://doi.org/10.1111/vec.12669

Publication

ISSN: 1476-4431
NlmUniqueID: 101152804
Country: United States
Language: English
Volume: 27
Issue: 6
Pages: 697-706

Researcher Affiliations

van Galen, Gaby
  • Department of Veterinary Clinical Sciences, University Copenhagen, University of Copenhagen, Denmark.
Rijckaert, Joke
  • the Equine Hospital, Faculty of Veterinary Medicine, University of Ghent, Belgium.
Mair, Tim
  • Bell Equine Veterinary Clinic, Maidstone, United Kingdom.
Amory, Helene
  • The Equine Hospital, Center for Fundamental and Applied Research for Animal and Health (FARAH), Faculty of Veterinary Medicine, University of Liege, Belgium.
Armengou, Lara
  • The Unitat Equina, Fundació Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, Spain.
Bezdekova, Barbora
  • The Equine Clinic, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic.
Durie, Inge
  • Evidensia Strömsholm Equine Hospital, Strömsholm, Sweden.
Findshøj Delany, Rikke
  • Department of Veterinary Clinical Sciences, University Copenhagen, University of Copenhagen, Denmark.
Fouché, Nathalie
  • the Swiss Institute of Equine Medicine (ISME), Vetsuisse Faculty, University of Bern, Switzerland.
Haley, Laura
  • the University Veterinary Teaching Hospital, School of Veterinary Medicine, University College Dublin, Ireland.
Hewetson, Michael
  • the Faculty of Veterinary Medicine, University of Helsinki, Finland.
van den Hoven, Rene
  • the Equine Hospital, Vetmeduni Vienna, Austria.
Kendall, Anna
  • the Equine Hospital, Faculty of Veterinary Medicine, University of Uppsala SLU, Sweden.
Malalana, Fernando
  • the Philip Leverhulme Equine Hospital, University of Liverpool, United Kingdom.
Muller Cavalleri, Jessika
  • the Clinic for Horses, University of Veterinary Medicine Hannover, Foundation, Germany, De Bosdreef, Moerbeke-Waas, Belgium.
Picavet, Tresemiek
  • the Clinic for Horses, University of Veterinary Medicine Hannover, Foundation, Germany, De Bosdreef, Moerbeke-Waas, Belgium.
Roscher, Katja
  • the Equine Clinic, Faculty of Veterinary Medicine, University of Giessen, Germany.
Verwilghen, Denis
  • Department of Veterinary Clinical Sciences, University Copenhagen, University of Copenhagen, Denmark.
Westermann, Cornélie
  • the Equine Hospital, Faculty of Veterinary Medicine, University of Utrecht, The Netherlands.
Saegerman, Claude
  • The Equine Hospital, Center for Fundamental and Applied Research for Animal and Health (FARAH), Faculty of Veterinary Medicine, University of Liege, Belgium.

MeSH Terms

  • Animals
  • Animals, Newborn
  • Europe / epidemiology
  • Horse Diseases / blood
  • Horse Diseases / epidemiology
  • Horse Diseases / pathology
  • Horses
  • Prognosis
  • Retrospective Studies
  • Survival Rate
  • Tetanus / epidemiology
  • Tetanus / pathology
  • Tetanus / veterinary

Citations

This article has been cited 4 times.
  1. Mendoza FJ, Toribio RE. An Overview of Donkey Neonatology. Animals (Basel) 2025 Jul 6;15(13).
    doi: 10.3390/ani15131986pubmed: 40646885google scholar: lookup
  2. Zitzl J, Dyckers J, Güssow A, Lehmann H, Hazuchova K. Survival in canine tetanus - retrospective analysis of 42 cases (2006-2020). Front Vet Sci 2022;9:1015569.
    doi: 10.3389/fvets.2022.1015569pubmed: 36590798google scholar: lookup
  3. de Smit H, Ackerschott B, Tierney R, Stickings P, Harmsen MM. A novel single-domain antibody multimer that potently neutralizes tetanus neurotoxin. Vaccine X 2021 Aug;8:100099.
    doi: 10.1016/j.jvacx.2021.100099pubmed: 34169269google scholar: lookup
  4. Popoff MR. Tetanus in animals. J Vet Diagn Invest 2020 Mar;32(2):184-191.
    doi: 10.1177/1040638720906814pubmed: 32070229google scholar: lookup